Guideline
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma - European Association for the Study of the Liver (EASL)
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.